|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.8 TWD | +1.42% |
|
-1.50% | -34.25% |
| 03-14 | Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 02-06 | Tanvex BioPharma, Inc. Announces the Appointment of James Williamson as Accounting Officer | CI |
Tanvex BioPharma, Inc. announced the appointment of James Williamson as Accounting Officer, effective February 6, 2024. James Williamson is VP of Finance of Tanvex BioPharma USA, Inc.
| 1st Jan change | Capi. | |
|---|---|---|
| -34.25% | 214M | |
| +7.52% | 111B | |
| +11.38% | 106B | |
| -12.64% | 22.24B | |
| +0.44% | 21.25B | |
| -4.18% | 18.97B | |
| -37.85% | 18.52B | |
| -8.58% | 16.81B | |
| +37.41% | 12.54B | |
| -23.95% | 8.09B |
TANVEX BIOPHARMA, INC. 